Moreover, PARP6 inhibits the expression of X-ray repair cross complementing 6 (XRCC6) by inducing its degradation, thereby affecting the Wnt/β-catenin signaling pathway and ultimately inhibiting the occurrence and development of HCC (58). This evidence concerns the gene XRCC6 and hepatocellular carcinoma.